Diabetes Testing: Evolving from Taste to Test
The History of Diabetes TestingCan you imagine diagnosing Diabetes by tasting urine? It’s hard...
Methotrexate Testing: An Alternate Diagnostic Option
Discontinuation of Abbott’s MTX Assay Creates Urgent Need in LabsDue to the importance of measuring...
Flu Season Outlook- Severity, Cost and Point-of-Care Testing
What’s happening in Australia could spell bad news for Europe and the United States (U.S). This...
Trichomonas Rapid Point-of-Care Testing: Uncovering Diagnostic Options
What is Trichomonas?
Trichomoniasis is a common, curable, non-viral sexually transmitted...
Open Channel Clinical Chemistry Analyzers- Unleashing the Potential
Did you know you have the ability to unlock your instruments potential and add assays that are not...
Quantifying the Value of Diagnostics: An AdvaMedDx Overview
Diagnostics: The Value of Accurate, Timely Medical CareWhile the cost-driven healthcare industry...
European Commission Launches New Plan to Address Antimicrobial Resistance
The British In Vitro Diagnostics Association (BIVDA) recently highlighted attention in Europe on...
Clinical Chemistry: Why Pour Over?
In the field of clinical chemistry, most manufacture instruments are intended for use with the...
Helping Save Patient’s Lives: Diagnosing Sepsis
Sepsis was identified as the most expensive in-patient cost in U.S. hospitals in 2014, costing...
FDA Reclassifies Rapid Antigen Influenza Testing
On February 13, 2017, the FDA’s reclassification of rapid antigen influenza testing became...